COMMUNIQUÉS West-GlobeNewswire

MiniMed(TM) 670G System Real-World Data on 8 Million Patient Days Shows 71 Percent Time in Range Across All Age Groups
28/05/2019
DUBLIN - May 28, 2018 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced real-world clinical outcomes for the MiniMed(TM) 670G system, which is being used by more than 180,000 people [...]
Imprivata Extends Healthcare’s Most Seamless EPCS Offering to Support Google Chrome
28/05/2019
Imprivata will showcase Imprivata Confirm ID for EPCS at the 2019 MUSE Inspire Conference LEXINGTON, Mass., May 28, 2019 (GLOBE NEWSWIRE) -- Imprivata® , the healthcare IT security company, today announced that [...]
Alphatec to Participate in the Jefferies 2019 Global Healthcare Conference and the Raymond James Life Sciences and MedTech Conference
28/05/2019
CARLSBAD, Calif., May 28, 2019 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (“ATEC” or the “Company”) (Nasdaq: ATEC), a provider of innovative spine surgery solutions dedicated to revolutionizing the approach to spine [...]
CrossBow with ADAPTOR Honored as Finalist in the 2019 Medical Design Excellence Awards
28/05/2019
Suture Ease, Inc., brings innovative technologies to laparoscopic surgery SAN JOSE, Calif., May 28, 2019 (GLOBE NEWSWIRE) -- Suture Ease, Inc. today announced that the CrossBow with ADAPTOR has been selected as a [...]
Galectin Therapeutics Raises $44.5 Million in Rights Offering and $2.5 Million from Warrant Exercise
28/05/2019
NORCROSS, Ga., May 28, 2019 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins, today announced its Rights Offering has closed. The Rights [...]
Sol-Gel Technologies Announces Seventh Agreement for Generic Product Candidates with Perrigo
28/05/2019
NESS ZIONA, Israel, May 28, 2019 (GLOBE NEWSWIRE) -- Sol-Gel Technologies, Ltd. (NASDAQ: SLGL) (“Sol-Gel” or the “Company”), a clinical-stage dermatology company focused on identifying, developing and commercializing [...]
Todos Medical Exercises Option to Acquire Remaining 80.01% of Breakthrough Diagnostics from Amarantus After Review of Alzheimer's Blood Test Data
28/05/2019
- Data demonstrated strong correlation between LymPro and amyloid PET - Todos to present at Alzheimer’s Solutions Conference on June 3, 2019 in Philadelphia - Todos to present at LD Micro on June 4 th , 2019 REHOVOT, [...]
Yield10 Bioscience, Inc. to Present at the Ladenburg Thalmann Technology Expo 2019 on May 30, 2019
28/05/2019
WOBURN, Mass., May 28, 2019 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ:YTEN), an agricultural bioscience company which uses its “Trait Factory” to develop high value seed traits for the agriculture and food [...]
Corvus Pharmaceuticals to Present at the Jefferies 2019 Global Healthcare Conference
28/05/2019
BURLINGAME, Calif., May 28, 2019 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company focused on the development and commercialization of precisely targeted [...]
Wildflower Featured in NetworkNewsWire Publication Highlighting Heightened Media Coverage of CBD Products
28/05/2019
NEW YORK, May 28, 2019 (GLOBE NEWSWIRE) -- via NetworkWire — Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), a multifaceted financial [...]
MyoKardia Presents Results from Phase 1a Clinical Trial of MYK-491 at the European Society of Cardiology Heart Failure Congress in Athens, Greece
28/05/2019
First-in-Human Data for MYK-491 in Healthy Volunteers Demonstrated Well-Tolerated Increases in Cardiac Contractility Topline Results from Phase 2a Clinical Trial of MYK-491 in Patients with Stable Heart Failure with [...]
Wildflower mise en avant dans la publication de NetworkNewsWire soulignant la couverture médiatique accrue des produits à base de CBD
28/05/2019
NEW YORK, 28 mai 2019 (GLOBE NEWSWIRE) -- via NetworkWire — Wildflower Brands Inc. (CSE : SUN) (OTCQB : WLDFF) a annoncé aujourd'hui son apparition dans une rubrique éditoriale publiée par NetworkNewsWire (« NNW »), une [...]
PDS Biotechnology to Present at the 9th Annual LD Micro Invitational
28/05/2019
BERKELEY HEIGHTS, N.J., May 28, 2019 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (“PDS Biotechnology”) (Nasdaq: PDSB), a clinical-stage immuno-oncology company pioneering the development of novel multifunctional [...]
AIT Therapeutics Presents On-Demand Nitric Oxide Study and Poster at the International Society for Aerosols in Medicine 2019 Congress in Montreux, Switzerland
28/05/2019
GARDEN CITY, N.Y. and REHOVOT, Israel, May 28, 2019 (GLOBE NEWSWIRE) -- AIT Therapeutics, Inc. (NASDAQ: AITB), a clinical-stage medical device and biopharmaceutical company focused on developing inhaled Nitric Oxide (NO [...]
Cassava Sciences Announces New Website Launch
28/05/2019
AUSTIN, Texas, May 28, 2019 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (Nasdaq: SAVA), a clinical-stage biotechnology company, announced today the launch of its newly designed website, www.CassavaSciences.com . Cassava [...]
Treos Bio Announces Positive Interim Results from a Phase 1/2 Clinical Trial of Precision Cancer Vaccine Plus Maintenance Therapy in Patients with Metastatic Colorectal Cancer
28/05/2019
Study will be presented in poster session at the 2019 ASCO Annual Meeting LONDON, May 28, 2019 (GLOBE NEWSWIRE) -- Treos Bio Limited, an immuno-oncology company developing next-generation, precision cancer vaccines [...]
Corcept Therapeutics to Present Data from Phase 1/2 Trial of Relacorilant Plus Nab-Paclitaxel in Patients with Solid Tumors at the American Society of Clinical Oncology Annual Meeting
28/05/2019
MENLO PARK, Calif., May 28, 2019 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of drugs that treat severe metabolic, oncologic [...]
Avid Bioservices to Participate at BIO International Convention 2019
28/05/2019
-- Company to Provide Insight on Key CDMO Industry Topics through Podium Presentation, Panel Discussion and Executive Interview as Part of Convention’s BioProcess International Theater -- -- Corporate Booth to Highlight [...]
Tyme Technologies to Present at the Jefferies 2019 Global Healthcare Conference on June 7, 2019
28/05/2019
NEW YORK, May 28, 2019 (GLOBE NEWSWIRE) -- Tyme Technologies, Inc. (NASDAQ: TYME) , an emerging biotechnology company developing cancer metabolism-based therapies (CMBTs™), announced that management will present at the [...]

Pages